Conference abstract · 19 May 2016
Conference abstractPublished 19 May 2016
Borderline ovarian tumors (BOTs)
Charité Medical University of Berlin, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Borderline ovarian tumors (BOTs) were first described by Taylor in 1929 and have been a challenge for both pathologists and oncologists. BOT is a disease of younger, fertile women, generally with a benign course; however, a minority of patients progress and eventually succumb to the disease. Although the corrected survival for patients with disease confined to the ovary is 100% at 15 years, 30% of patients with serous BOT with invasive implants will develop persistent or recurrent tumor, most commonly low-grade ovarian serous carcinoma. For the group of patients with invasive implants, there is no consensus regarding standard therapy. At present, chemotherapy is offered mostly to patients with invasive implants, regardless of histological subtype. However, response to these agents remains suboptimal with recurrence estimates for patients for patients with BOT with invasive implants undergoing adjuvant treatment remaining high at 44.0%. In this presentation we will discuss the current evidence, or lack of thereof, to support the use of adjuvant treatment in patients with invasive implants in the primary treatment setting.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2019
Oncology and Cancer Stem Cell 2018: Prognostic factors for surgical outcome and survival in women treated for borderline ovarian tumors - Medhat Esam Eldin Helmy - Cairo University, Egypt
Case report · 1 Jan 2017
Ovarian endometrioid borderline tumor arising from an endometriotic cyst
Conference abstract · 19 May 2016
MR spectroscopy in the differentiation of benign, borderline and malignant cystic epithelial ovarian tumors
Conference abstract · 19 May 2016
Effect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group study
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ines Vasconcelos”
